GSK’s ovarian cancer treatment meets main goal in late-stage study
GlaxoSmithKline said on Monday a late-stage study testing its initial maintenance therapy, Zejula, in patients with ovarian cancer who have undergone platinum-based chemotherapy showed positive results. Reuters Health News
In Charge of Animal Disease Study, and Surveillance Bureau, expert on Disease Study, Surveillance, Early Warning/Response, Client Training, and Development. Executive Officer for projects avoiding spread of diseases. Works at Iran Veterinary Organization; Veterinarian, 2000 - present.